Greater Than One, a New York-based integrated full-service health and wellness marketing agency, announced that industry-renowned brand builder Jodi Brichan joined GTO as Chief Growth Officer.
If you are not happy with the results below please do another search
50 search results for:
Novartis’ Sandoz division will not make a profit on 15 generic drugs the company is making available to developing countries to treat symptoms of COVID-19, the Swiss drugmaker said on Thursday.
Mallinckrodt Announces U.S. Food and Drug Administration (FDA) Advisory Committee Voted to Recommend Terlipressin for Approval to Treat Patients with Hepatorenal Syndrome Type 1 (HRS-1) – If approved, terlipressin would be the first FDA-approved treatment in the United States for adult patients with HRS-1, a life-threatening condition – – Prescription Drug User Fee Act (PDUFA) […]
Nanobodies derived from llamas have neutralized the SARS-CoV-2 spike in the lab, effectively neutralizing the virus, according to research from the UK’s Rosalind Franklin Institute.
According to data published in The New England Journal of Medicine, a Phase I trial of Moderna’s mRNA vaccine against SARS-CoV-2 demonstrated promising safety and immune response in all patients involved in the study.
Glympse Bio secured $46.7 million in a Series B fundraising round that will be used to support continued development of the company’s novel biosensor platform in fibrotic diseases such as non-alcoholic steatohepatitis (NASH), oncology and infectious diseases.
Calcium Founder & CEO Steven Michaelson announced the addition of Gene Fitzpatrick and June Carnegie to the full-service, independent healthcare marketing agency’s executive leadership team.
Merck CEO Ken Frazier says the first vaccines against Covid-19, should they meet the 50 percent efficacy threshold set by the U.S. Food and Drug Administration, may not have as broad of an impact as hoped.
More than 75 countries expressed interest in joining the COVAX financing scheme designed to guarantee fast and equitable access globally to Covid-19 vaccines, the GAVI vaccines alliance said,
Russian scientists hailed the results of their first clinical trial of a potential coronavirus vaccine, saying it had been proved safe and that volunteers had developed an immune response.